Vietnam
Arcturus obtains approval for Phase IIIb Covid vaccine trial in Vietnam
The trial will have nearly 20,000 subjects, who will receive two doses of the vaccine 28 days apart or a placebo.
The trial will have nearly 20,000 subjects, who will receive two doses of the vaccine 28 days apart or a placebo.